chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had more weakness; This spontaneous case was reported by an other caregiver and describes the occurrence of ASTHENIA (had more weakness) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Heart valve disorders and Defibrillator/pacemaker insertion.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (had more weakness). At the time of the report, ASTHENIA (had more weakness) outcome was unknown. Not Provided          No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-075153 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075153:dose 1
DIZZINESS; STOMACH PAIN; This spontaneous report received from a patient concerned a 48 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcohol user, and non-smoker, and other pre-existing medical conditions included no known allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, expiry: 07-AUG-2021) dose was not reported, administered on 22-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-JUL-2021, the subject experienced dizziness. On 23-JUL-2021, the subject experienced stomach pain. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizziness, and stomach pain. This report was non-serious.
This case was reported by a physician via sales rep and described the occurrence of fever in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever and joint pain. On an unknown date, the outcome of the fever and joint pain were unknown. It was unknown if the reporter considered the fever and joint pain to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The age group was not provided, but was selected adult as per the vaccine indication. Caller heard from the physician that he had seen three patients who after receiving 1st dose of SHINGRIX, experienced low grade fever and joint aches. This case has been linked with cases US2018157969 and US2018157978, reported by the same reporter.
Rash at injection site -> generalized rash with itch w/in 3 hrs.
Swollen tongue and throat.  Diagnosed as angioedema.  Treated with epinephrine, benadryl, oxygen, and IV lines.  Took a few days to recover.
Rec'd HIB/MMR 24JAN91 developed fever of 101 31JAN91, rash on 4FEB91 which cleared 5MAR91; Also had pharyngitis & diarrhea of 30JAN91;
Patient had mild bilateral knee and hip pain 1 month ago, then she received her 1st dose of COVID vaccine on 12/14/20. Her joint pain worsened then on 1/4/21 she received her 2nd dose of COIVD vaccine on 1/4/21 and then her pain increased in spread up to her shoulders. She was seen at immediate care on 1/11/21 because her joint pain had worsened throughout and her shoulder pain was making it difficult to raise her arms above the level of her shoulders. Her pain was made worse w/ movement.
Elbows were dry; Muscle soreness at COVID vaccine site; This spontaneous case was reported by a consumer and describes the occurrence of DRY SKIN (Elbows were dry) and VACCINATION SITE PAIN (Muscle soreness at COVID vaccine site) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Psoriatic arthritis.    Concurrent medical conditions included Psoriatic arthritis.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced DRY SKIN (Elbows were dry) and VACCINATION SITE PAIN (Muscle soreness at COVID vaccine site). At the time of the report, DRY SKIN (Elbows were dry) had not resolved and VACCINATION SITE PAIN (Muscle soreness at COVID vaccine site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  Treatment information was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Tinnitus, ringing in ears, sensitive to sound, pain.  Started after injection.  Was only given a vaccine card.  No information given on side effects to look for.  Was not aware until later that tinnitus was a side effect from vaccine
Pt complained of deltoid pain since receiving Anthrax #3. Since had Anthrax #4 in left - problems. Had intermittent soreness since. Increasingly complaining of pain, July 2000. Has not consulted a physician about symptoms.  Follow up on 12/21/2000: "Patient partially recovered from adverse event.  Still experiences some sharp pain and stiffness in upper right arm.  Patient did not receive any further shots since reported event."
first dose 2 years ago, can still have second; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose of shingrix 2 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: Age at vaccination was not applicable for this report. The patient asked if they could receive second dose now. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. Consent to follow up was not possible as no contact details were available.
Patient received his 3rd HPV vaccine today. 90 min later, the patient reports his arm feels numb. He states same thing happened after receiving 2nd vaccine. Numbness lasted 2-3 days.
Moderna vaccine is currently not EUA for patients under the age of 18 and it was administered to a 12 year old patient. No reaction/adverse effects reported.
Rash spreading to chest and arms; Rash in injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash spreading to chest and arms) and VACCINATION SITE RASH (Rash in injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced RASH (Rash spreading to chest and arms) and VACCINATION SITE RASH (Rash in injection site). At the time of the report, RASH (Rash spreading to chest and arms) and VACCINATION SITE RASH (Rash in injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment Antibiotics and cefadroxil
Red streaks, hot to touch, fever x 3 d 100.4, 101.4, headache. Tx with antiviral, antibiotics, TYLENOL. (LD).
This spontaneous report as received from a pharmacist refers to a 82 year old patient. No information about medical history, concurrent conditions and concomitant medications were reported. The reporter stated that on 23-JUL-2014 the patient was vaccinated with expired dose of ZOSTAVAX (strength, route, dose not reported) lot number J0022 with expiry of 21-MAY-2014. Pharmacist stated that registered nurse (RN) at physician office administered vaccine and vaccine date was discovered when nurse was logging information. No adverse effects reported. The outcome of events reported is unknown. No product quality complaint was involved. Additional information has been requested.
Initial report received from a non-health care professional on 17 October 2013. A male patient whose birth date and age at the time of event, medical history and concomitant medication were not reported, had received a dose of FLUZONE HD (lot number, dose number and anatomical site of administration were not reported) on 14 October 2013. The patient had no illness at the time of vaccination. On 14 October 2013 after vaccination, the patient experienced pain in the arm where vaccine was injected, and swelling of the lymph nodes under the arm in the axillary area. Symptoms had persisted for four days with no improvements but also not becoming worse. No laboratory investigations were done and corrective medications were not reported. At the time of this report, the patient had not recovered from events. Documents held by sender: none
My body turned cold then followed by hot flashes coughing with blood. Low fever muscle pain but I had bronchitis two weeks prior next day cough wheezing completely gone and my lungs feel great I can breathe again with no mucus I have swollen lymph nodes but not to bad little headache but overall feeling ok just tired and some dizziness at times.
pain/excruciating pain in her bones, and all over her body; pain in her bones; under her arm was swollen; under her arm was swollen and very painful; having pain in her breast; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient got her second COVID vaccine shot on 07Jan2021, and was in pain and under her arm was swollen and very painful and she was having pain in her breast as well. Patient was in excruciating pain in her bones, and all over her body. Caller was taking paracetamol (TYLENOL) but that didn't help too much. Outcome of all events was not recovered.   Information about batch/lot number has been requested.
@ 1429, Client arrived for 1st dose Moderna.  Vaccinator administered ½ dose (Booster Dose).  Error was caught,   Situation was explained to client.  Client was vaccinated with another ½ dose of Moderna.  Client finished Observation period and left clinic.
Vertigo starting one day after vaccine and resolving spontaneously after 3 days, also had some sweating (did not check for a fever)
Patients who got Moderna had the same symptoms as me; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Patients who got Moderna had the same symptoms as me) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Patients who got Moderna had the same symptoms as me). At the time of the report, VACCINATION COMPLICATION (Patients who got Moderna had the same symptoms as me) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product was provided by the reporter.  No treatment medication was provided.  Reporter stated that her Chiropractor had some patients who had received the Moderna vaccine and experienced the same symptoms as the reporter.
This spontaneous report as received from a pharmacist refers to a patient of an unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On 15-NOV-2017, the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX 23 lot number L029113, expiration date 27-MAR-2017, intramuscularly (dose was not reported) for prophylaxis (expired product administered).
Presented to ER at Hospital on 3/25, symptom onset 3/23,  with bleeding from multiple sites, found to have platelet count of 0. Confirmed to have immune thrombocytopenic purpura based on presence of platelet-bound IgG  with full hematological evaluation for other causes which included bone marrow biopsy. Has been treated with high dose daily steroids, IV immune globulin three doses on 3/27 -3/29,  rituximab on 3/31, romiplostim started on 4/1 weekly, 11 units of platelets. Has not yet achieved a sustained clinical response to treatment.
Patient had acute acute COVID19 in October 2021. Got her first COVID19 vaccine on 11/12/21. Started having fever on 11/16/21and was admitted on 11/21 /21 with MIS-C with Cardiac involvement. Was hospitaized from 11/21/21-11/25/21. Her COVID19 (Nucleocapsid) IgG was positive.
Given after exp date 09/30 but stability data  supports use of product through 10/19/22
Got the vaccine, her arm didn't hurt to touch, but if she moved it the pain was terrible.  The evening of the vaccine she started to feel achy, deep down in her muscles.  She was extremely tired, sick to her stomach and headache for 4 days.  She had a fever, and actually had chills, her hands were trembling.  By Sunday 3/14/21 subsided now, but the headache, achiness, and other symptoms stayed until Monday.  She is still achy and tired after almost 3 weeks.  She took Advil or Tylenol for the reaction.  The fever ranged from 100 - 101 sporadically at different times, which lasted for about a day and a half.   Due to this reaction she has decided not to have the 2nd vaccine.
Prolonged menstrual cycle- 11 day flow  Headache Body aches  Sore arm  Fatigue
her disabled daughter (50 year old, female) also received the first vaccine at the same time she did. Her daughter also experienced the Covid virus when she did as well.; her disabled daughter (50 year old, female) also received the first vaccine at the same time she did. Her daughter also experienced the Covid virus when she did as well.; This is a spontaneous report from a contactable Other health care professional (HCP) (patient mother). A 50-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 19Mar2021 as dose 1, single for covid-19 immunisation. Medical history included disabled. The patients concomitant medications were not reported. Patient stated that her disabled daughter also received the first vaccine at the same time she did on 19Mar2021. Her daughter also experienced the Covid virus when she did as well on an unspecified date. The patient underwent lab tests and procedures which included sars-cov-2 test: experienced the covid virus on an unspecified date. The outcome of the events were unknown.   No follow-up attempts are possible. Information on Batch number, Lot number cannot be obtained.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported drug ineffective and COVID-19 cannot be ruled out.
This spontaneous report as received from a registered medical assistant refers to a patient of unknown age. The patient was vaccinated with the first time of GARDASIL (Lot # not reported) on 02-AUG-2012, the second dose of GARDASIL (Lot # not reported) on 09-OCT-2012 and the third dose of GARDASIL (Lot # not reported) on 07-JAN-2013. No adverse symptoms were reported. Additional information has been requested.
This spontaneous report as received from a consumer refers to his 68 year old female wife with "cholesterol" and high blood pressure and no drug reactions/allergies. On 28-OCT-2013 the patient was vaccinated with a dose of ZOSTAVAX, VIAL, (lot #, expiration date, dose and route unspecified) for vaccination. Concomitant therapies included atorvastatin and atenolol. On 29-OCT-2013, the patient developed an injection site reaction following vaccination with ZOSTAVAX. The injection site reaction was described as a reddish, warm, "knot" at the injection site of the ZOSTAVAX vaccination. The consumer reported that the injection site reaction peaked on Wednesday (30-OCT-2013) and seemed to be getting better (less red and less warm). At the time of report, the patient was recovering from the events. No lab diagnostics studies performed. The patient had not sought medical attention. No treatment was given. Additional information has been requested.
Body aches, slight fever and chills that lasted for 30 minutes. Took Tylenol for aches and fever. Started feeling better on 11/07/2014.
Fainting, headache, nausea, and eye pain. All began around 11 hours after receiving the 2nd dose of Pfizer.
On Friday, March 12, 2021, at the pharmacy I had an 8:00 am appointment to receive the Johnson & Johnson?s Janssen COVID-19 Vaccine. I received my vaccine in the left arm but the injection seemed to me (and my wife) to be in an odd location, which was very high up on the shoulder near the shoulder joint. Things seemed fine until Saturday evening when I started to feel some tightness in my left trapezius between my scapula and my occipital bone. By Sunday morning that same area was very tight and painful; what we used call a ?crick.? Sunday afternoon I began to feel some sharp pain in my left shoulder joint. I had very little sleep on Sunday night and by Monday morning I had significant pain in what felt like my humerus.  I made an appointment with a chiropractor  for Monday afternoon and he suggested the vaccine shot might have started an inflammation that led to the tight trapezius, which in turn was causing the cervical spinal nerves to react, thus causing the pain in my arm. At this point I was in a lot of pain and the pain was moving further down toward my elbow. The chiropractor did his usual things and told me to put ice on it and take OCT Ibuprofen and or Naproxen. I was a bit better on Tuesday and decided to attend a three-day pastors? retreat. By Tuesday afternoon the pain had expanded to just below my elbow. I consulted with a doctor friend and he thought it was likely that I was having a reaction to the vaccine and that it would pass. He as concerned to hear of the odd location of my injection. I had another sleepless night and on Wednesday I noticed that the ends of my left thumb and index finder were numb and by that night the numbness had expanded to include most of my index finder. The other arm and shoulder pain continued but varied in intensity. On Wednesday morning I called my wife and asked her to come get me at the retreat and that afternoon I called my doctor's office office and made an appointment for Thursday morning (3-18-21). I'm  feeling the cumulative effects of the pain and fatigue. My overall pain level is a little less but still present, as is the numbness in my index finger and thumb. My doctor suggested the nerve inflammation was a reaction tot he vaccine.
COVID arm; Rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm) and RASH (Rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm) and RASH (Rash). At the time of the report, VACCINATION SITE REACTION (COVID arm) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant Medications were reported. No Treatment Information Provided.
Urticaria on back, upper extremities, abdomen. Treated with topical aloe/calamine (no antihistamine, per pharmacist, because pt on stimulants.
Patient received her 2nd dose of the Pfizer COVID-19 vaccine on 9/7/2021 and was due for a 3rd booster dose on 2/7/2022. Patient's booster dose was administered early on 1/18/2022 by pharmacist because it was not identified that it was too soon for her booster dose until after administration. Spoke with CDC representative and booster is considered valid. Patient notification completed and patient was advised of side effects to monitor for. Patient reported feeling fine on 1/19/2022 at 5pm and had not experienced any side effects from the vaccine. Patient will follow up with the pharmacy and primary care doctor with any concerns or adverse effects if they occur.
Information has been received from a physician concerning a healthy 5.5 year old female with a history of strep throat and no allergies who in early 2005 (approximately January 2005), was vaccinated with a first dose of hepatitis A virus vaccine inactivated and on 9/15/05 was vaccinated with a second dose of hepatitis A virus vaccine inactivated (lot # 649459/0287R). There was no concomitant medication. On 9/25/05, 10 days after vaccination, the patient developed double vision. On 9/26/05, the patient was unable to get out of bed and unable to walk. Two to three hours later, her speech became slurred and she had mental status changes. She was taken to the emergency room and was unable to walk or talk. She was admitted to the hospital and within 30 minutes was intubated. She was given IV immune globulin. She became unresponsive and her status was worsening. Plasmaphoresis was initiated. A methylprednisolone sodium succinate pulse was begun in the morning of 9/30/05. .She was also given Cytoxin. An MRI and MRA were performed (results not provided). Laboratory tests included CSF (test not specified) and a sedimentation rate and C-reactive protein were high. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Double vision, unable to get out of bed/unable to walk, speech became slurred, mental status changes, unable to talk, and unresponsive were considered to be immediately life threatening, disabling, and other important medical events by the physician (OMIC). Additional information has been requested.
This spontaneous report was received from a consumer refers to a 60 year old male patient concerning himself. The patient did not have any medical history and drug reactions/allergies or concurrent conditions. Approximately 15-JAN, about a week and half ago, the patient was vaccinated with ZOSTAVAX "one single shot" (dose number, lot# and expiration date were not reported). On an unspecified date in January 2015, the patient developed nasopharyngitis and jaw pain. The outcome of developed nasopharyngitis and jaw pain was reported as not recovered/not resolved. The patient received treatment with ibuprofen (dose, frequency unknown). Additional information has been requested.